Rejected at 3:02 p.m. Jan, 30, 2024 ] by Ahmed7
Author: helen.nguyen
Related Note: 1485313550723
Rationale for change

Potential duplicate with Anki id: 1484950427352

"{{c1::Naltrexone}} is a μ-opioid antagonist that helps maintain abstinence in opioid addicts once detoxified"

Rejection reason

resolved manually, thank you

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::13_Psych::02_Pathology::41_Psychoactive_drug_intoxication_and_withdrawal::*Depressants::Opioids #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::13_Medically_supervised_opioid_withdrawal_and_relapse_prevention #AK_Step1_v12::#Low/HighYield::1-HighYield #PANCE::EOR::PSYCH #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::04_Opioid_Classification #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#SketchyPsych::10_Substance_Use/_Medication_Related_Disorders::01_Substance_Use_Overview #AK_Step2_v12::#UWorld::COMLEX::115559 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Psychiatry_/_Psychology #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::21_Naloxone #AK_Step2_v12::Original_decks::Zanki_Step_2::Psych::Step_1_Psych #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::30_Opioid_Withdrawal,_Detoxification_and_Relapse_Prevention #AK_Step2_v12::#Resources_by_rotation::Psych::step1_psych_zanki #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step2_v12::#UWorld::Step::20489 #AK_Step1_v12::^Systems::Psychiatry #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::17_Full_Opioid_Agonists #AK_Step1_v12::#Low/HighYield::4-LowerYield #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::21_Opioid_Clinical_Use,_Mechanism_and_Overdose #AK_Step2_v12::#UWorld::Step::105925 #AK_Step2_v12::#OME::04_Psychiatry::17_Addiction_2_Drugs_of_Abuse #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::13_Medically_supervised_opioid_withdrawal_and_relapse_prevention::04_Naltrexone #AK_Step1_v12::#B&B::19_Psych::03_Substance_Use_Disorders::02_Opioids #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::19_Naltrexone #PANCE::BEHAVIORAL::substance_use #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::01_Anesthetics_&_Analgesics::03_Opiates,_Naloxone,_Naltrexone #AK_Step2_v12::!Shelf::EM #AK_Step1_v12::#B&B::19_Psych::03_Substance_Use_Disorders::01_Alcohol_and_CNS_Depressants::Extra #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::#AMBOSS::DH01sh #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::22_Naltrexone #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step2_v12::#B&B::13_Psych::03_Substance_Abuse::01_Alcohol_Use_Disorder